Medication Adherence in Older People With Psychosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00071604|
Recruitment Status : Unknown
Verified April 2008 by Veterans Medical Research Foundation.
Recruitment status was: Active, not recruiting
First Posted : October 30, 2003
Last Update Posted : May 6, 2013
|Condition or disease||Intervention/treatment||Phase|
|Psychotic Disorders Schizophrenia||Behavioral: Medication Adherence Therapy Behavioral: Friendly Support Group||Not Applicable|
Psychoses are among the most common and serious psychiatric disorders. Currently, the most effective treatment for psychoses involves the use of antipsychotic or neuroleptic medications. Unfortunately, pharmacologic regimens often do not achieve their goals because of poor medication adherence. Nonadherence to antipsychotic treatment is a considerable public health problem that leads to myriad clinical and economic burdens, including psychotic relapse, increased clinic and emergency room visits, and rehospitalization.
Participants in this study are randomly assigned to receive either MAT or supportive treatment for 12 weeks. MAT is given in 15 sessions and consists of motivational interviewing, education, and social skills and behavior modification. Individual MAT sessions are held in Weeks 1 and 12; small group sessions take place in Weeks 2 through 11. Three monthly booster group sessions begin in Week 16. Participants are assessed at baseline and at 3, 6, and 12 months. Medication adherence, psychopathology, quality of life, medication side effects, health beliefs, and functioning are assessed.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||240 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Medication Adherence in Older Psychotic People|
|Study Start Date :||September 2002|
|Study Completion Date :||May 2007|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00071604
|United States, California|
|Division of Geriatric Psychiatry Center (University of California, San Diego)|
|San Diego, California, United States, 92161|
|Principal Investigator:||Jonathan Lacro, PharmD||VA San Diego Healthcare System & University of California, San Diego|